CVS Caremark to cover Zepbound
Digest more
Eli Lilly (LLY) just did something worth paying attention to. With CVS Caremark announcing coverage of both Zepbound and ...
Morning Overview on MSN
Eli Lilly’s new obesity pill just stripped 85 pounds off patients in a late-stage trial — the steepest weight loss ever logged without a needle
Participants in Eli Lilly’s TRIUMPH-1 trial lost an average of roughly 85 pounds on the highest dose of retatrutide, an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results